SoCal.StartupsBe an early user

Antlia Bioscience, Inc.

Encinitas, CA
LAST FUNDING
$6.0M
Seed

Developing novel long-acting therapeutics targeting chronic cardiometabolic diseases.

Funding history

DateRoundAmountInvestorsSource
Seed$6.0M

About Antlia Bioscience, Inc.

How much funding has Antlia Bioscience, Inc. raised?

Antlia Bioscience, Inc. has raised $6.0M in total funding. The most recent round was Seed.

Where is Antlia Bioscience, Inc. headquartered?

Antlia Bioscience, Inc. is headquartered in Encinitas, CA.

What does Antlia Bioscience, Inc. do?

Developing novel long-acting therapeutics targeting chronic cardiometabolic diseases.

What's Antlia Bioscience, Inc.'s solution?

Antlia Bioscience develops novel long-acting therapeutics targeting chronic cardiometabolic diseases.

What makes Antlia Bioscience, Inc. notable?

Founded in 2020 by Brian Johnson and Nigel Shankley, the San Diego biopharma has raised roughly $6.2M developing long-acting peptide therapies for cardiometabolic disease.

Leadership

Brian Laurence Johnson
Executive Officer, Director
Ankit Mahadevia
Executive Officer, Director
Ben Auspitz
Director
Carlos Echeverria
Director
Nihal Sinha
Director
Martin Taylor
Director
❝ Cite this page

Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.

MLA
"Antlia Bioscience, Inc.: Funding & Investors." SoCal.Startups, August 26, 2026, https://socalstartups.io/companies/city/encinitas/healthcare/antlia-bioscience-inc. Accessed August 27, 2026.
APA
SoCal.Startups. (2026). Antlia Bioscience, Inc.: Funding & Investors. Retrieved August 27, 2026, from https://socalstartups.io/companies/city/encinitas/healthcare/antlia-bioscience-inc
WIKIPEDIA (CITE WEB)
{{cite web |title=Antlia Bioscience, Inc.: Funding & Investors |url=https://socalstartups.io/companies/city/encinitas/healthcare/antlia-bioscience-inc |website=SoCal.Startups |access-date=August 27, 2026}}